Robert Farrell

Robert Farrell

Director Ejecutivo en CLARITAS PHARMACEUTICALS, INC. .
76 años
Health Technology
Commercial Services
Consumer Services

Perfil

Robert Edward Farrell is currently Chairman, President & Chief Executive Officer at Claritas Pharmaceuticals, Inc. since 2021.
He is also a Director at AEENA Dx, Inc. and a Member of The State Bar of California.
Former roles include President & Chief Executive Officer at Titan Pharmaceuticals, Inc. from 2008 to 2009; Independent Director at Bionovo, Inc. in 2012; President, Chief Financial Officer & Director at Kalytera Therapeutics, Inc.; Chief Financial & Accounting Officer at BioVest International, Inc. from 2013 to 2014; Chief Financial Officer at Sanovas, Inc. from 2012 to 2013; Associate General Counsel at Brae Corp.
in 1982; Vice President-Marketing at Genstar Corp.
from 1982 to 1990; Chief Financial Officer at Amarantus Bioscience Holdings, Inc. from 2014 to 2016; Chief Financial Officer at PATH Drug Solutions; CFO, Group VP & General Counsel at Fresenius Securities, Inc. and Fresenius Medical Care Holdings, Inc. from 1991 to 1996.
Education includes undergraduate studies at the University of Notre Dame and graduate studies at the University of California, Hastings.

Cargos activos de Robert Farrell

EmpresasCargoInicio
CLARITAS PHARMACEUTICALS, INC. Director Ejecutivo 21/06/2017
Director/Miembro de la Junta -
Corporate Officer/Principal -

Antiguos cargos conocidos de Robert Farrell.

EmpresasCargoFin
AMARANTUS BIOSCIENCE HOLDINGS, INC. Director Financiero/CFO 01/07/2016
Director Financiero/CFO 01/05/2014
Director Financiero/CFO 30/11/2013
TITAN PHARMACEUTICALS Director Ejecutivo 01/01/2009
Director Financiero/CFO 01/08/1996
Ver el detalle de la experiencia de Robert Farrell.

Formación de Robert Farrell.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

77

Relaciones de 1er grado

16

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas16

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Transportation

Commercial Services

Consumer Services

Commercial Services

Miscellaneous

Health Technology

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN